Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain
CompletedOBSERVATIONAL
Enrollment
93
Participants
Timeline
Start Date
July 31, 2003
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Conditions
Rheumatoid ArthritisInflammation
Interventions
DRUG
Etanercept
Trial Locations (1)
28007
Madrid
All Listed Sponsors
lead
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
NCT00195364 - Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain | Biotech Hunter | Biotech Hunter